Healthcare provider profile · identity verified

Kevin Dabundo, D.O.

Family Practice · WEST CHESTER, PA · NPI 1811258866

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	318	93
Lisinopril	Lisinopril	221	64
Rosuvastatin Calcium	Rosuvastatin Calcium	205	66
Amlodipine Besylate	Amlodipine Besylate	184	58
Levothyroxine Sodium	Levothyroxine Sodium	182	47
Losartan Potassium	Losartan Potassium	134	42
Sertraline Hcl	Sertraline Hcl	132	43
Omeprazole	Omeprazole	109	33
Pantoprazole Sodium	Pantoprazole Sodium	95	31
Alprazolam	Alprazolam	93	26
Hydrochlorothiazide	Hydrochlorothiazide	89	31
Metoprolol Succinate	Metoprolol Succinate	83	24
Metformin Hcl	Metformin Hcl	82	25
Tramadol Hcl	Tramadol Hcl	81	13
Lorazepam	Lorazepam	75	25
Simvastatin	Simvastatin	71	20
Fluoxetine Hcl	Fluoxetine Hcl	58	16
Zolpidem Tartrate	Zolpidem Tartrate	57	15
Fluticasone Propionate	Fluticasone Propionate	54	14
Gabapentin	Gabapentin	53	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	43
Eliquis	Apixaban	46	11
Clonazepam	Clonazepam	45	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Famotidine	Famotidine	42	14
Albuterol Sulfate Hfa	Albuterol Sulfate	40	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	18
Furosemide	Furosemide	39	11
Prednisone	Prednisone	39	20
Tamsulosin Hcl	Tamsulosin Hcl	38	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Allopurinol	Allopurinol	34	12
Ozempic	Semaglutide	34	suppressed
Atenolol	Atenolol	33	suppressed
Potassium Chloride	Potassium Chloride	32	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Ramipril	Ramipril	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	17
Ezetimibe	Ezetimibe	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Meloxicam	Meloxicam	21	11
Valacyclovir	Valacyclovir Hcl	21	11
Bupropion Xl	Bupropion Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Azithromycin	Azithromycin	19	18
Diazepam	Diazepam	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Valsartan	Valsartan	18	suppressed
Xarelto	Rivaroxaban	17	suppressed
Mounjaro	Tirzepatide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Carvedilol	Carvedilol	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Finasteride	Finasteride	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error